Tardive dyskinesia can affect many areas of your life, including your social life and self-confidence. Learning how to manage these effects can help improve your overall well-being and daily ...

In 2024, several research and pharmacological advancements were made for tardive dyskinesia, a movement disorder caused by dopamine-blocking medications. Below are some of the highlights of the year.

So one of the trials that I'm interested in watching is an extension trial of the IMPACT-TD registry that's currently going on and being done by Teva Pharmaceuticals, who are the manufacturers of ...

Tardive dyskinesia is a hyperkinetic movement disorder that causes faces to move involuntarily and abnormally. It is considered to be a drug-induced movement disorder. Movements often occur in the ...

Patients on antipsychotics need to be regularly monitored for signs of tardive dyskinesia, a medication-induced movement disorder diagnosed when the involuntary movements persist for at least a month ...

Combination NOAC therapy. Patients receiving treatment with antipsychotic agents would benefit from screening for tardive dyskinesia as these repetitive movements can negatively affect quality of life ...

Currently there are two FDA approved treatment options for tardive dyskinesia. There are two medications that are VMAT2 inhibitors. These are valbenazine (Ingrezza) and deutetrabenazine (Austedo) made ...

This section presents medications that are known to potentially lead to 'Dyskinesia' as a side effect. It's important to note that mild side effects are quite common with medications. Please be aware ...

Tardive dyskinesia (TD) is a condition that causes uncontrollable, repetitive movements in different parts of your body, such as your face, limbs, and torso. This neurological disorder not only ...

Amantadine extended-release (ER) capsules reduce levodopa-induced dyskinesia (LID) in patients with Parkinson's disease (PD), a phase 3 placebo-controlled trial has shown. "Our study showed that this ...